FindTrial
Sign In

A Clinical Study to Assess the impact of Virechan Karma on Gut Microbiome Balance.

A Randomized Controlled Clinical Study to Evaluate the Effect of Virechan Karma over the Gut Microbiome Modulation - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/03/105309
Enrollment
30
Registered
2026-03-03
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

RGGPG Ayurvedic College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Volunteers who are apparently healthy. Volunteers between age group of 18 to 60 years. Volunteers who provide informed consent form for Virechan karma. Volunteerts fit for Virechan Karma.

Exclusion criteria

Exclusion criteria: Volunteers contraindicated for Virechan Karma as per classics. Volunteers below 18yrs and above 60yrs of age. Individuals with severe Gastrointestinal Diseases. Volunteers having uncontrolled Hypertension, Diabetes Mellitus Pregnant women and lactating mothers.

Design outcomes

Primary

MeasureTime frame
To assess the efficacy of Virechan Karma over the Gut Microbiome modulation and its potential role in restoring microbial balance and overall health Timepoint: 33 days—

Secondary

MeasureTime frame
a)To compare gut microbiome alterations in subjects undergoing Virechan Karma versus a control group. b)To analyse biochemical changes before and after the intervention. Timepoint: 33 days—

Countries

India

Contacts

Public ContactDr Nisha Jallundhara

Rajiv Gandhi Government Postgraduate Ayurvedic College and Hospital Paprola , Kangra HP

anil5karma@gmail.com9418466766

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026